Calviri Publishes Results Demonstrating Sensitive Detection of Stage 1 Tumors in Dogs - Candlesense

Calviri Publishes Results Demonstrating Sensitive Detection of Stage 1 Tumors in Dogs

PHOENIX, June 17, 2025 /PRNewswire/ -- Calviri, Inc, a company focused on ending cancer in dogs and people, announces the publication of High-sensitivity multicancer detection of stage 1 cancer in dogs in the American Journal of Veterinary Research of a novel diagnostic for the sensitive...